1. Pristimerin targeting NF‐κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells
   Yuanqing Tu et al, 2018, Cell Biochemistry and Function CrossRef
2. Role of the AMPK signalling pathway in the aetiopathogenesis of ocular diseases
   Dhaval K Shukal et al, 2022, Human & Experimental Toxicology CrossRef
3. Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway
   Qun Zhao et al, 2021, Phytomedicine CrossRef
4. The application of natural compounds in uveal melanoma drug discovery
   Yihe Niu et al, 2022, Journal of Pharmacy and Pharmacology CrossRef
5. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma
   Yue Xu et al, 2019, Journal of Cellular Biochemistry CrossRef
6. Pristimerin in Oxidative Stress and Use in Cancer
   Ana Carolina B. da C. Rodrigues et al, 2021, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
7. The multifaceted mechanisms of pristimerin in the treatment of tumors state-of-the-art
   YingZheng Wang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
8. Development and Validation of an HPLC-PDA Method for Biologically Active Quinonemethide Triterpenoids Isolated from Maytenus chiapensis
   Vito Taddeo et al, 2019, Medicines CrossRef
9. ATTEMPTS TO SYNTHESIZE A TRIMERIC DERIVATIVE OF PRISTIMERIN WITH POTENTIAL ACTIVITY AGAINST CANCER CELLS
   Josana Pereira Dos Santos et al, 2024, Revista Contemporânea CrossRef
10. Signaling pathways driving ocular malignancies and their targeting by bioactive phytochemicals
    Courtney R. Croley et al, 2023, Pharmacology & Therapeutics CrossRef
11. The Interplay between Tumour Microenvironment Components in Malignant Melanoma
    Cornelia Amalinei et al, 2022, Medicina CrossRef
12. Pristimerin alleviates cigarette smoke-induced inflammation in chronic obstructive pulmonary disease via inhibiting NF-κB pathway
    Dongsheng Huang et al, 2022, Biochemistry and Cell Biology CrossRef
13. Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
    Elaine C. D. Gonçalves et al, 2020, Molecules CrossRef
14. Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells
    Yingbing Zhang et al, 2019, International Journal of Molecular Medicine CrossRef
15. Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
    Run-Ze Chen et al, 2021, Frontiers in Oncology CrossRef
16. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy
    Simin Zhang et al, 2020, Molecular Biology Reports CrossRef
17. Synergistic anti-cancer effect of pristimerin and docetaxel on human colorectal HCT-116 cells
    Bashir A. Yousef et al, 2020, Synergy CrossRef
18. Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway
    Qiang Wan et al, 2020, BMC Molecular and Cell Biology CrossRef
19. Pristimerin in Oxidative Stress and Use in Cancer
    Ana Carolina B. da C. Rodrigues et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
20. Pristimerin‐induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway
    Fengxia Yan et al, 2020, Journal of Cellular and Molecular Medicine CrossRef